Survival prognostic factors in patients with glioblastoma: Our experience

Journal of Neurosurgical Sciences

Volumn 56, Issue 3, 2012, Pages 239-245

  Raysi Dehcordi, S ^a   De Paulis, D ^b   Marzi, S ^b   Ricci, A ^b   Cimini, A ^a   Cifone, M G ^a   Galzio, R J ^a,b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

Author keywords

Depression; Glioblastoma; Survival; Survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; DEPRESSION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; BRAIN TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK FACTOR; STATISTICS; SURVIVOR;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DEPRESSIVE DISORDER; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; SURVIVORS;

EID: 84868256459     PISSN: 03905616     EISSN: 18271855     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M et al. Long-term survival with glioblastoma multiforme. Brain 2007;130:2596-606. (Pubitemid 47511715)
2. Smith JS, Jenkins RB. Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 2000;5:D213-31.
3. Ohgaki H, Dessen P, Jourde B, Hortsmann S, Nishikawa T, Di Patre PL et al. Genetic patways to glioblastoma: a population-base study. Cancer Res 2004;64:6892-9. (Pubitemid 39330996)
4. Steinbach JP, Blaicher HP, Herrlinger U, Wick W, Nägele T, Meyermann R et al. Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology 2006;66:239-42. (Pubitemid 43970162)
5. Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 1999;85:485-91. (Pubitemid 29051306)
6. Kowalczuk ABA, Macdonald RL, Amidei CRN, Dohrmann G 3rd, Erickson RK, Hekmatpanah J et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 1997;41:1028-38. (Pubitemid 27475463)
7. Stummer W, Tonn J-C, Mehdorn HM, Nestler U, Franz K, Goetz C et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. J Neurosurg 2011;114:613-23
8. Lacroix M, Abi-Said D, Fourney DR, Gokaslan Z L, Shi W, De-Monte F et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190-98. (Pubitemid 32799739)
9. Sanai N, Polley M-Y, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011;115:3-8.
10. Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett B, Brem B, Quiñones-Hinojosa A. Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. J Neurosurg 2011;114:604-12.
11. Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P. Depression and functional outcome in patients with btrain tumors: a population based 1 year follow-up study. J Neurosurg 2005;103:841-47. (Pubitemid 43194578)
12. Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 2002;57:41-9. (Pubitemid 34692613)
13. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr. Depression in patients with high grade glioma: results of the Glioma Outcome Project. Neurosurgery 2004;54:358-66.
14. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Paychiatry 2003;54:269-82. (Pubitemid 37267857)
15. Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer 2002;94:2719-27. (Pubitemid 34478089)
16. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96. (Pubitemid 40349501)
17. Yasargil MG. Neocerebral and neocerebellar tumors. In: Yasargil MG, editor. Microneurosurgery of CNS Tumors. New York, NY: Thieme Classics; 1996. p. 238-51.
18. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology 2003;5:79-88. (Pubitemid 36422560)
19. Ammirati M, Vick N, Liao Y, Ciric I, Mikhael M. Effect of the extent of surgical resection on serviva and quality of life in patients with supratentorial gliblastomas and anaplastic astrocytomas. Neurosurgery 1987;21:201-6. (Pubitemid 17131119)
20. Anderson SI, Taylor R, Whittle IR. Mood disorders in patients after treatment for primary intracranmial tumors. Br J Neurosurg 1999;13:480-5. (Pubitemid 29457381)
21. D'Angelo C, Mirijello A, Leggio L, Ferulli A, Carotenuto V, Icolaro N et al. State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1 year longitudinal study. J Neurosurg 2008;108:281-6. (Pubitemid 351213291)
22. Litofsky NS, Farace E, Anderson Jr F, Meyers CA, Huang W, Laws ER Jr. Depression in patients with high grade glioma: results of the Glioma Outcomes Project. [comments]. Neurosurgery 2004;54:358-67. (Pubitemid 38209404)
23. Wellisch DK, Kaieita TA, Freeman D, Cloughesy T, Goldman J. Predicting major depression in brain tumor patients. Psycooncology 2002;11:230-8. (Pubitemid 34618588)
24. Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A et al. Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surgical Neurology 2009;71:299-303.
25. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54-269-82.
26. Morford LA, Elliott LH, Carlson SL, Brooks WH, Roszman TL. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 1997;159:4415-25. (Pubitemid 127470601)
27. Black KL, Chen K, Becker DP, Merrill JE. Inflammatory leukocytes associated with increased immunosuppression by glioblastoma. J Neurosurg 1992;77:120-6.
28. Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem Res 2007; 32:1749-56. (Pubitemid 47428863)
29. Morgenson GJ, Brudzynski SM, Wu M, et al. From motivation to action: a review of limbic, nucleus accumbens, ventral pallidum, pedunculopontine nucleus circuitries involved in limbic motor integration. In: Kalivas PW, Barnes CD, editors. Limbic motor circuits and neuropsychiatry. Boca Raton, FL: CRC Press; 1993. P. 193-236.
30. Abosch A, Cosgrove GR. Biological basis for the surgical treatment of depression. Neurosurg Focus 2008;25:E2.
31. Irle E, Peper M, Wowra B, Kunze S. Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol 1994;51:164-74. (Pubitemid 24051580)
32. Foley KM, Gelband H. Improving palliative care for cancer: national cancer policy board, institute of medicine and national research council. Washington, DC: National Academy Press; 2001.